Literature DB >> 7513019

Recent advances in immunobiology of brain tumors.

M Tada1, N de Tribolet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7513019     DOI： 10.1007/bf01049981

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  74 in total

Review 1.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

2.  Constitutive and PMA-induced interleukin-1 production by the human astrocytoma cell line T24.

Authors:  J C Lee; P L Simon; P R Young
Journal:  Cell Immunol       Date:  1989-02       Impact factor: 4.868

3.  Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes.

Authors:  A Olofsson; K Miyazono; T Kanzaki; P Colosetti; U Engström; C H Heldin
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

4.  Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist.

Authors:  S M Wahl; G L Costa; M Corcoran; L M Wahl; A E Berger
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

5.  Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

Authors:  A Koff; M Ohtsuki; K Polyak; J M Roberts; J Massagué
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

6.  Divergent responses of human astrocytoma and non-neoplastic astrocytes to tumor necrosis factor alpha involve the 55 kDa tumor necrosis factor receptor.

Authors:  B P Barna; G H Barnett; B S Jacobs; M L Estes
Journal:  J Neuroimmunol       Date:  1993-03       Impact factor: 3.478

7.  Human glioblastoma cells produce 77 amino acid interleukin-8 (IL-8(77)).

Authors:  M Tada; K Suzuki; Y Yamakawa; Y Sawamura; S Sakuma; H Abe; E van Meir; N de Tribolet
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

8.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

Authors:  G Del Prete; M De Carli; F Almerigogna; M G Giudizi; R Biagiotti; S Romagnani
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

9.  Imbalances in T cell subpopulations in human gliomas.

Authors:  M K Bhondeley; R D Mehra; N K Mehra; A K Mohapatra; P N Tandon; S Roy; V Bijlani
Journal:  J Neurosurg       Date:  1988-04       Impact factor: 5.115

10.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors:  C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  11 in total

Review 1.  Models for assessment of angiogenesis in gliomas.

Authors:  R H Goldbrunner; S Wagner; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme.

Authors:  T Schneider; R Gerhards; E Kirches; R Firsching
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

3.  Human astrocytoma cells are capable of producing macrophage inflammatory protein-1beta.

Authors:  N Ishii; M Tada; S Sakuma; Y Sawamura; Y Shinohe; H Abe
Journal:  J Neurooncol       Date:  1998-03       Impact factor: 4.130

4.  Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Lauren Bryan; Steven W Paugh; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Dmitri Kapitonov; Hanna Rokita; Sarah Wright; Irene Griswold-Prenner; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

5.  The alteration of prostaglandin E2 levels in patients with brain tumors before and after tumor removal.

Authors:  Joon-Khim Loh; Shiuh-Lin Hwang; Ann-Shung Lieu; Tzuu-Yuan Huang; Shen-Long Howng
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

6.  Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interleukin-2.

Authors:  U Herrlinger; R Buchholz; P Jachimczak; M Schabet
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

7.  Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.

Authors:  Denise A Caruso; Lisa M Orme; Alana M Neale; Fiona J Radcliff; Gerlinda M Amor; Wirginia Maixner; Peter Downie; Timothy E Hassall; Mimi L K Tang; David M Ashley
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

Review 8.  New aspects of immunotherapy of leptomeningeal metastasis.

Authors:  U Herrlinger; M Weller; M Schabet
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

Review 9.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

Authors:  Gavin P Dunn; Ian F Dunn; William T Curry
Journal:  Cancer Immun       Date:  2007-08-13

10.  In silico experimentation of glioma microenvironment development and anti-tumor therapy.

Authors:  Yu Wu; Yao Lu; Weiqiang Chen; Jianping Fu; Rong Fan
Journal:  PLoS Comput Biol       Date:  2012-02-02       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.